Infliximab discontinuation in patients with ulcerative colitis

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)412-413
Number of pages2
JournalThe Lancet Gastroenterology and Hepatology
Volume6
Issue number6
DOIs
StatePublished - Jun 2021

Funding

FundersFunder number
AbbVie
Takeda Pharmaceutical Company
Janssen Pharmaceuticals

    Cite this